Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study) | MicrobiomeTrials← Back to trialsNCT07772570
Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study)
RecruitingOBSERVATIONAL
Trial Details
Start: 2012-05Est. Completion: 2046-09
Enrollment target: 2,000 participants Locations- Oxford Heart Centre, John Radcliffe Hospital, Oxford, United Kingdom
Other microbiome trials you might be interested in
Post-operative Atrial FibrillationCardiovascular DiseasesPost-pericardiotomy Syndrome
The goal of this observational study is to test the association between high levels of Galectin-3 and the occurrence of …
São Paulo, BrazilEst. completion Jan 27, 2026
Persistent Atrial Fibrillation
LANCE-AF is a prospective, multicenter, multinational, randomized, non-inferiority trial comparing two pulsed-field abla…
Paris, FranceEst. completion Mar 2030
DeliriumCardiac Surgical ProceduresCoronary Artery Bypass Graft (CABG)Valve SurgeryPostoperative Complications
This retrospective observational study uses de-identified electronic health records from the TriNetX Global Collaborativ…
Taichung, TaiwanCompleted Jul 31, 2025